| Lightcalls.com |
|
|
![]() |
Think of treatments for heart disea...Think of treatments for heart disease, and what be deriveds to mind? Intense diet and exercise? Bypass surgery? Angioplasty? Multiple drugs? Chances are you didn't say prayer, meditation or touch therapy. if it were not that if the results of near new studies prove to be constant maybe you should. In about of the latest research, doctors at Duke University Medical Center analyzed 150 heart patients undergoing various treatments, including angioplasties. They divided the patients into five assemblages All received medical treatment, moreover four groups also got single in kind of the following: touch therapy, relaxation training, exercise s in using guided imagery or being prayed for without their knowledge. Results? Patients who received any of the additional therapies were 25 to 30 percent les likely to bring out complications from their medical treatment than those who recieved nothing extra. "We know from past studies that relaxation exercises, meditation and being gently touched and cared for can have deep effects on the heart. These activities decrease blood pressure, heart rates and stres hormones," says Harold G Koenig, MD internist, psychiatrist and director of the Center for the contemplation of Religion, Spirituality and Health at Duke "But in this case, the collection with the lowest complication rates was the common being unknowingly prayed for. There's no scientific explanation for that." This is not an isolated finding in heart health. The originates echo a similar study done last year at St Luke's Hospital in Kansas City, Mo Doctors there examineed at 990 patients who had been admitted to a cardiac-care unit. About half of their first names were given to an outside assemblage that prayed for them for a month The patients were unaware of what was happening, nevertheless they had 11 percent fewer cardiac complications, and the complications be attentive toed to be less serious than in those patients who weren't prayed for. for a like reason what does all of this mean? "We don't know," says William s Harris, M.D., professor of medicine at the University of Missouri in Kansas City, who headed the St Luke's meditation "At the moment, we've merely shown that an association exists between being prayed for and having an improved consequence How it works is way beyond anyone's understanding fight now. nevertheless I think these studies point out to that research on nonphysical orderly dispositions of healing is legitimate and can be done objectively and scientifically." The Duke researchers are planning a large nationwide cogitation in hopes of replicating their findings. Meanwhile, doctors emphasize that these treatments were always used in addition to--not instead of--proven medical care. "People shouldn't stop taking any medication because someone is praying for them," says Koenig. "Nor should doctors push religion upon patients or pray with them without their requesting it. if it were not that if patients want to pray onward their own, I think we should encourage it. It's also reassuring to know that if we're praying for someone to procure well, we just may make a difference." COPYRIGHT 2002 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |